Olympic Cool-Cap System

The Olympic Cool-Cap System is the only FDA approved device for the treatment of hypoxic-ischemic encephalopathy (HIE) in term infants. It works by utilizing a unique cooling cap to provide selective brain cooling while maintaining core temperature at safe levels through the use of a radiant warmer.

Studies have shown that if used in the first six hours of life, the system can prevent or significantly reduce the severity of neurologic injury associated with HIE.

• Brain-targeted cooling offers new hope for infants affected by HIE
• Neonatologists at Arkansas Children's Hospital treat first infant with the Olympic Cool-Cap System
• FDA Patient Safety News Featuring the Olympic Cool-Cap System
• CoolCap Trial, Treatment of Perinatal Hypoxic-Ischemic Encephalopathy
• Determinants of Outcomes After Head Cooling for Neonatal Encephalopathy